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Discovery of Swine as a
Host for the Reston ebolavirus
Roger W. Barrette,1 Samia A. Metwally,1* Jessica M. Rowland,1 Lizhe Xu,1 Sherif R. Zaki,2
Stuart T. Nichol,2 Pierre E. Rollin,2 Jonathan S. Towner,2 Wun-Ju Shieh,2 Brigid Batten,2
Tara K. Sealy,2 Consuelo Carrillo,1 Karen E. Moran,1 Alexa J. Bracht,1 Gregory A. Mayr,1
Magdalena Sirios-Cruz,3 Davinio P. Catbagan,3 Elizabeth A. Lautner,1 Thomas G. Ksiazek,2†
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Since the discovery of the Marburg and Ebola species of filovirus, seemingly random, sporadic
fatal outbreaks of disease in humans and nonhuman primates have given impetus to
identification of host tropisms and potential reservoirs. Domestic swine in the Philippines,
experiencing unusually severe outbreaks of porcine reproductive and respiratory disease syndrome,
have now been discovered to host Reston ebolavirus (REBOV). Although REBOV is the only member
of Filoviridae that has not been associated with disease in humans, its emergence in the human
food chain is of concern. REBOV isolates were found to be more divergent from each other than
from the original virus isolated in 1989, indicating polyphyletic origins and that REBOV has been
circulating since, and possibly before, the initial discovery of REBOV in monkeys.
Filoviruses are associated with acute fatalhemorrhagic diseases of humans and/ornonhuman primates. The family consists
of two genera: Marburgvirus, which comprises
various strains of the Lake Victoria marburgvirus
(MARV) discovered in 1967; and the antigeni-
cally distinct genusEbolavirus discovered in 1976,
which comprises five species including Sudan
ebolavirus (SEBOV), Zaire ebolavirus (ZEBOV),
IvoryCoast ebolavirus [also known asCote d’Ivoire
Ebola virus (CIEBOV)], Bundibugyo ebolavirus
(BEBOV), and Reston ebolavirus (REBOV) (1).
REBOV is the only member of the family thus
far not associated with disease in humans (2).
Since the discovery of filoviruses more than
40 years ago, ostensibly random, sporadic, and
fatal outbreaks of disease in primates have evoked
interest in delineation of host tropisms, potential
reservoirs for disease transmission, and persistence
in nature (3). These lines of investigation have
recently identified African fruit bats as potential
reservoirs for ZEBOV (4, 5) and MARV (6, 7).
Similar links to bats have been found for emerging
infections in swine and humans involving para-
myxoviruses and the severe acute respiratory
syndrome (SARS) coronavirus (8, 9).
Until now, REBOV has only been associated
with disease in nonhuman primates (2, 10). The
virus was originally identified in 1989 in the United
States from a shipment of cynomolgus monkeys
(Macaca fascicularis) from the Philippines. Out-
breaks of disease occurred in the United States in
1990 and 1996 and in Italy in 1992, which were
traced back to a single facility in the Philippines
(fig. S1) (11, 12). Here, we report the identifica-
tion of REBOV infection in domestic swine co-
infected with porcine reproductive and respiratory
syndrome virus (PRRSV) that were experiencing
a severe respiratory disease syndrome.
In July 2008, the Philippine Department of
Agriculture requested the assistance of the U.S.
1Foreign Animal Disease Diagnostic Laboratory, National
Veterinary Services Laboratories, Animal and Plant Health
Inspection Services, United States Department of Agri-
culture, Plum Island Animal Disease Center, New York,
NY 11944, USA. 2Special Pathogens and Infectious Dis-
ease Pathology Branches, Centers for Disease Control and
Prevention, Atlanta, GA 30333, USA. 3Bureau of Animal
Industry, Department of Agriculture, Quezon City 1101,
Philippines.
*To whom correspondence should be addressed. E-mail
michael.t.mcintosh@aphis.usda.gov (M.T.M.); samia.a.
metwally@aphis.usda.gov (S.A.M.)
†Present address: Galveston National Lab, Department of
Pathology, University of Texas Medical Branch, Galveston,
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Fig. 1. Detection of REBOV in swine samples from the Philippines. (A) Composition of the panviral microarray
used to detect REBOV. The microarray feature composition is summarized with reference to the number of
unique features for identification of viral pathogens. FMDV, foot-and-mouth disease virus. (B) Microarray
analysis of Vero cell culture of a swine lymph node from sample group A identified multiple positive features
within the genus of Ebola viruses. These features corresponded primarily to sequences from REBOV with
minimal reactivity toward SEBOV and ZEBOV. MFI, mean fluorescence intensity (△) Positive Reston ebolavirus
spp. features; (◇) positive Ebolavirus genus features; (◯) non-Ebolavirus features; and (●) negative features.
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Department of Agriculture (USDA), Animal and
Plant Health Inspection Service (APHIS), Foreign
Animal Disease Diagnostic Laboratory (FADDL),
in the diagnostic investigation of recent multiple
outbreaks of a respiratory and abortion disease
syndrome in swine. Clinical signs resembled a
highly pathogenic PRRSV infection, also referred
to as “blue ear disease,” which has recently been
spreading through Asia (13–15). Sera and tissue
samples were collected from five groups of swine
at two commercial premises located in Pandi,
Bulacan (sample group A); Manaoag, Pangasinan
(sample groups C and E); and two inspection
check points located in Sto. Nino, San Jose City,
Nueva Ecija (sample group B) and Batangas
(sample group D) (fig. S1). The diagnostic in-
vestigation at FADDL included diagnostics for
African swine fever and classical swine fever, a
directed investigation for the presence of PRRSV,
and a more general search of other viral agents
potentially contributing to the disease. Selected
tissue samples from each group were tested and
found negative for the presence of African swine
fever, classical swine fever, swine vesicular dis-
ease, and foot-and-mouth disease. Consistent with
a respiratory and reproductive disease syndrome,
PRRSV was discovered. Sequence analysis of the
NSP2 gene revealed that it was most homologous
to Chinese PRRSV isolates recently associated
with blue ear disease in Asia. This determination
was based on the presence of two unique dele-
tions in theNSP2 gene of the Philippines PRRSV
isolate that are shared by recent Chinese PRRSV
isolates associated with pathogenic PRRS inAsia
(14, 16). Simultaneously, a lymph node from group
A, cultured in Vero cells, a monkey kidney cell
line nonpermissive for PRRSV, revealed cytopathic
effects indicating the presence of a virus other
than PRRSV.
To resolve such unexplained cases, a panviral
microarray has been developed that used a near-
neighbor approach for the identification of taxo-
nomically conserved viral protein microdomains.
This tool consists of tens of thousands of con-
served viral genetic signature sequences micro-
scopically arrayed on a slide and is designed to
capture extracted and amplified viral nucleic
acid from a query sample (Fig. 1A). It is similar
in concept and design to previously published
pathogen microarrays, including a panmicrobial
array named the GreeneChip (17, 18) and the
Fig. 2. Immunohistopathol-
ogy of EBOV and PRRSV. (A)
Lymph node capsule stained
for EBOV antigens. (B) Lymph
node tissue stained for EBOV
antigens. (C) Lung tissue
stained for EBOV antigens.
(D) Lung tissue stained for
PRRSV antigens. (E) Lymph
node germinal center stained
for PRRSV antigens. (A to E)
Immunoalkaline phosphatase
staining, naphthol fast red sub-
strate with light hematoxylin
counterstain. (F) Filovirus par-
ticle by negative-staining elec-
tronmicroscopy of the E6 Vero
cell culture of the lymph node.
Scale bar, 100 nm.
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Fig. 3. Phylogeny of REBOV. (A) Full-length genomic sequences for
Reston08-A, Reston08-C, and Reston08-E were experimentally deter-
mined, with the exception of the defined 5′ and 3′ termini, and aligned.
Nucleotide similarity scores and the number of predicted amino acid
changes between swine and monkey REBOV genomes are shown. (B) A
consensus neighbor-joining tree drawn without distance topology il-
lustrates the independent branching of the three 2008 Philippine swine
viruses within the REBOV clade, demonstrating the divergence between each of these viruses. The percent
branching out of 1000 random bootstrap iterations is indicated above each branch.
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ViroChip used to characterize the SARS coro-
navirus (19).
To identify the unknown virus, the Vero cell
culture was subjected to microarray analysis. Re-
sults revealed positive signals for 28 out of 28
distinct array features present in a 3.7-kb span of
the REBOV L gene (Fig. 1B). By contrast, only 3
out of 30 and 2 out of 30 features were positive
for the ZEBOVand SEBOV species, respectively.
No other notable signals other than controls were
positive (Fig. 1B). Because microarray results are
sequence dependent, polymerase chain reaction
(PCR) primers designed from the features them-
selves were used to PCR amplify and sequence
the viral cDNA captured by the microarray slide.
This sequence analysis confirmed that the cap-
tured viral sequences were more than 95% iden-
tical to the L gene of all previously sequenced
REBOV isolates. Because REBOV is classified
as a biological safety level 4 select agent, samples
were transferred to the Special Pathogens Branch
at the Centers for Disease Control and Prevention
(CDC) (Atlanta, Georgia), and identification of
REBOV was confirmed by Ebola-specific real-
time reverse transcription (RT)–PCR analysis
(table S1), antigen enzyme-linked immuno-
sorbent assay, immunohistochemistry, and virus
isolation in E6 Vero cell culture.
REBOV was only found in sample groups
that also tested positive for PRRSV (table S1).
Histopathological and immunohistochemical ex-
amination of lymph nodes from animals infected
with REBOVand PRRSV from groups A and C
showed different patterns of antigen localization
and pathology (Fig. 2, A, B, and E). REBOV
antigens were seen focally in lymphoid and lymph
node capsule tissues with minimal necrosis (Fig. 2,
A and B), whereas PRRSVantigens were seen in
the germinal centers of lymphoid follicles display-
ing germinal cell hyperplasia and focal necrosis
(Fig. 2E). Immunostaining of lung tissues for
REBOVand PRRSV revealed localization of both
viral antigens in areas displaying mixed inflam-
matory cells and sloughed necrotic debris in al-
veolar spaces consistentwith interstitial pneumonia
(Fig. 2, C and D). Negative-staining electron mi-
croscopy of the E6 Vero cell culture of the lymph
node from the Bulacan site (group A) revealed
filamentous virus particles and partially assem-
bled intermediate particles characteristic of filovi-
ruses (Fig. 2F). Serological studies on 13 swine
sera from groups A, B, and D for the detection of
antibodies to REBOVwere negative. In contrast,
antibodies to PRRSVwere detected in swine sera
from each of the tested sample groups A, B, and D.
RT-PCR revealed REBOV nucleic acid in
animals from groups C and E, at the Pangasinan
site, and from group A at the Bulacan site (fig. S1
and table S1). Samples from groups B and D did
not test positive for REBOVor PRRSV; however,
PCR revealed porcine circovirus type 2 (PCV-2)
among samples fromgroupsA,B, andD (table S1),
and microarray analysis further revealed Porcine
teschovirus 1 from the SK6 porcine kidney cell
culture of a tonsil from group D.
Viral genomes for REBOV identified from
three samples—designatedReston08-A,Reston08-
C, and Reston08-E—at two geographically distinct
locations were ~18.9 kb in length and confirmed
that the viruseswere REBOV species (Fig. 3). The
Reston08 viruses were significantly more diver-
gent from each other (3.93% mean difference in
nucleotide identity) than from the prototypical
reference isolate from 1989 (2.5%mean difference
in nucleotide identity), indicating polyphyletic ori-
gins of the REBOV infections in swine at both
locations (Fig. 3A).
The lack of a phylogenetic clade, distinct from
viruses in macaques, for the recent REBOV in-
fections in swine (Fig. 3B) suggests that REBOV
has been circulating since, and possibly before,
the initial discovery of REBOV in monkeys ex-
ported from the Philippines in 1989. The isolation
of REBOV from swine represents an extension in
the known host tropism. The interisolate diver-
gence of the three recent swine isolates is greater
than that observed among the monkey isolates
obtained from the single implicated primate ex-
port facility (Fig. 3A). Given the broader genetic
diversity and geographic distribution of REBOV
in swine, it is possible that REBOV spilled over
tomonkeys and swine from an as yet unidentified
host. Bats have been implicated as reservoirs for
other filoviruses, including ZEBOVand MARV,
and may also represent a candidate reservoir for
REBOV.
Of 141 tested individuals, we identified 6
individuals who worked on pig farms or with
swine products that had positive serum immuno-
globulin G (IgG) titers to REBOV, confirming
the potential transmission from pigs to humans.
The remaining 135 individuals tested negative
for IgG titers to REBOV. Given the observed
sequence divergence between the Reston08 vi-
ruses, a broader surveillance program is being
planned. REBOV infection in domestic swine
raises concern about the potential for emerging
disease in humans and a wider range of live-
stock. However, as in previous REBOV inci-
dents, there is no evidence of disease in humans
despite the apparent occurrence of human infec-
tions evidenced by seropositive titers of REBOV-
specific antibody.
The role of swine as either an incidental host
or an integral part of the virus’s transmission cy-
cle has yet to be determined. Because evidence of
coinfection with PRRSV, an arterivirus, was found
with REBOV, we can speculate about a link be-
tween coinfection and disease in swine. This
possibility is of interest in light of the atypical,
highly pathogenic infections in swine by PRRSV
that are currently spreading through Asia (14–16).
Simian hemorrhagic fever virus, a well-known
pathogen of captive primates and also an arterivirus
of previously characterized pathogenicity, was iden-
tified in a coinfection of monkeys during the first
detected outbreak of REBOV (20), although later
studies clearly demonstrated the pathogenicity of
REBOV as a single agent in experimentally in-
fected monkeys (21).
There is concern that its passage through swine
may allow REBOV to diverge and shift its poten-
tial for pathogenicity. Moreover, REBOV infections
in swine highlight the need for investigations into
the pathogenesis of REBOV in coinfections or in
immunocompromised hosts. Through domestic
and international interdisciplinary cooperation and
collaboration, it is expected that future epidemiol-
ogy and pathogenesis studies will shed light on the
potential reservoirs, mode(s) of transmission, mech-
anisms of pathogenesis, prevalence of REBOV in
nature, and its consequences for agricultural in-
dustries and trade.
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Materials and Methods 
 
Panviral microarray design and analysis.  A near-neighbor comparison was developed 
to identify taxonomically conserved viral peptide microdomains which were then used to 
identify 10,768 virus family, genus and/or species specific oligonucleotide features used 
to build the panviral microarray.  (-) ssRNA virus-specific features included both sense 
and antisense sequences.  This array was supplemented with various conserved viral 
genetic signatures from foreign animal disease diagnostic assays and selected viruses to 
achieve 13,181 unique disease pathogen features (Fig. 2A) with an estimated total 
theoretical detection coverage for all human, animal, avian and fish viruses with 
corresponding sequence in the 2007 NCBI virus nucleotide sequence database. Random 
primed sample cDNA was PCR amplified, labeled with biotin using a BioNick™ kit 
(Invitrogen) and hybridized to the microarrays at 67 oC for 16 hr in Agilent CGH 
microarray hybridization buffer (Agilent Technologies).  Microarrays were developed 
with 1mM AlexaFluor–546 Streptavidin (Invitrogen) in PBST (2X PBS, 0.1% Tween-20, 
1% Bovine Serum Albumin) 30min prior to a final wash and data collection using 
Genepix v.6.1 (BioRad). 
 
Characterization of REBOV.  Full genome sequence analyses were performed on 
REBOV derived from group A (lung tissue and the Vero cell culture of a lymph node, 
both from a single animal), group C (a pool of two lymph nodes from different animals), 
and group E (the Vero cell culture of a pool of three spleens from different animals).  
Histopathology and morphology of PRRSV and REBOV were studied by 
immunoalkaline phosphatase staining of formalin-fixed paraffin-embedded tissues and 
negative staining electron microscopy of virus from sample group A isolated from E6 
Vero cell culture. 
 
Random cDNA amplification for microarray analysis.   RNA was extracted from the 
Vero cell culture of a lymph node from site A using RNeasy (Qiagen) and treated with 
DNA-free DNAse (Ambion).  Random cDNA was generated using RT Superscript II 
(Invitrogen) and two primers GTTTCCAAGTCACGATCNNNNNNNNN and 
GTTTCCAAGTCACGATCTTTTTTTTTTTT.   Product was treated with RNase H 
(Invitrogen) at 37 oC for 30 minutes followed by treatment with a QiaQuick PCR spin 
column (Qiagen).  Random cDNA was then 3’ tagged using T4 RNA ligase 1 (New 
England Biolabs) and a second tag primer modified by 5’ phosphorylation and a 2',3'-
dideoxycytidine pAAGGTTCACATTTGTAATG-ddC.  Ligation was performed 4 hr at 
22 oC in 1x T4 RNA Ligase 1 buffer (New England Biolabs) supplemented with 25% 
(w/v) PEG 8000 and 2.5 nM second tag primer (S1).   Amplification was then performed 
for 36 cycles using tag complementary primers GTTTCCAAGTCACGATC and 
CATTACAAATGTGAACCTT.  Product was cleaned using QiaQuick PCR spin 
columns (Qiagen).   
 
 2
PCR methods.  Molecular detection of PCV-2 was performed from sample DNA 
obtained using a Qiagen DNA mini kit (Qiagen) and PCR using primers PCV-F: 
GCTGAACTTTTGAAAGTGAGCGGG and  
PCV-R: TCACACAGTCTCAGTAGATCATCCCA  with Platinum Taq Supermix 
(Invitrogen) and at  94 oC for 12 min followed by 40 cycles of 94 oC for 60 sec, 58 oC for 
60 sec, and 72 oC for 60 sec.  This yielded a 243 bp PCV specific product that was further 
digested with Nco-I (New England Biolabs) to distinguish PCV-2 from PCV-1. 
 Molecular detection of PRRSV was performed from sample RNA obtained using 
an RNeasy Mini kit (Qiagen) and RT-PCR using RT Superscript II followed by the 
Advantage 2 PCR kit (Invitrogen) using PRRSV-F: GRACTTCCTCARCTTCTTGC and 
PRRSV-R: TCGACGAGCTTAAAGACCAGA primers.  Thermocycling conditions 
included denaturing at 95 oC for 2 min, followed by 35 cycles of 95 oC for 30 sec, 55 oC 
for 30 sec, and 68 oC for 60 sec (Guillermo Risatti, personal communication). 
 Molecular detection of REBOV L gene was performed from sample RNA 
obtained using an RNeasy Mini kit (Qiagen).  RT-PCR was performed using RT 
Superscript II followed by Platinum Taq Supermix (Invitrogen) with primers REBOV-
ER3-F: ACGAGTATATCCTGTGCACAAATCTCCTTAG and REBOV-ER3-R: 
CGAAGGCAGTTCCAATACTGGCAAGTGTTCC primers.  PCR conditions were 94 
oC for 12 min followed by 40 cycles of 94 oC for 60 sec, 58 oC for 60 sec, and 72 oC for 
60 sec. 
 Genome amplification of REBOV was performed from extracted RNA and RT-
PCR was performed as previously described (S2).  Denaturing was 94 oC for 2 min 
followed by 35 cycles of 94 oC for 15 sec, primer specific annealing temperatures for 30 
sec, and 68 oC for 60 sec per 1 kb of expected product size.  Primers and annealing 
temperatures were as follows:  REBOV-1F: CGGACACACAAAAAGAAA and 
REBOV-NP-2R-1090: CAAGAAATTAGTCCTCATCAATC, annealing at 48 oC; 
REBOV-NP-1F-754:  GTATTTGGAAGGTCATGGATTC and REBOV-3080-R: 
AGTAAACACCTGCCTACAGA, annealing at 48 oC; REBOV-2841-F: 
ACTTACACCGGTCTATCCA and REBOV-5800-R: GAGCATTCAGAATATTGCTT, 
annealing at 45 oC; REBOV-5571-F: AGCAGAGGCAACAGACTC and REBOV-8640-
R: GAACACGAATTTGGGATG, annealing at 47 oC; REBOV-8481-F: 
ATCCGGATGATGGAGCAT and REBOV-11921-R: CTGTGCACCTGTTGCCTT, 
annealing at 51 oC; REBOV-11741-F: TGATACACCTGTAGCAACA and REBOV-
13279-R: CATAAAGTTTGGACATTCC, annealing at 43 oC; REBOV-13031-F: 
GGATGCAGTCTTTGAACC and  REBOV-14760-R: GTACAGGTGTCTCACTGTTG, 
annealing at 47 oC, REBOV-14581-F: TGGAAGATGAGATGGTTTG and REBOV-
18894-R: GGACACACAAAAAGGAAAA, annealing at 47 oC. 
 Realtime RT-PCR detection of Ebola was performed on sample RNA using 
Superscript III One-Step RT-PCR (Invitrogen), 50 uM forward primer  
AGTIACMAGTGCMTGTGGGA, 50 uM reverse primer 
GGCAGTTCCWATACTGGCAAGT and 10 uM probe 6-FAM-
CAATCACTCAARACAGCAGCWAGIATGGC-BHQ-1 at 50 oC for 15 min and 95 oC 
for 2 min followed by 40 cycles of 95 oC for 15 sec and 56 oC for 45 sec.  Results were 
recorded using an ABI7500 (Applied Biosystems). 
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Genomic sequence analyses.  Eight overlapping RT-PCR products spanning the 
complete genomes of REBOV from each of the three sample groups (groups A, C and E) 
were generated and used for genome sequence determination.  Products were treated with 
ExoSAP-IT® (USB Corporation), sequenced using the BigDye® Terminator v3.1 Cycle 
Sequencing kit (Applied Biosystems), purified with CleanSeq® (Agencourt), and 
analyzed on the 96-capilary 3730xl DNA Analyzer (Applied Biosystems).  Viral genomic 
ends were not experimentally determined.  The Reston08-A sequence represents a 
composite of sequences obtained from two tissue samples from the same animal that 
were independently amplified and sequenced and which differ only in completeness of 
the 5’ and 3’ end regions.  All shared sequence between these two independent sequence 
determinations (18,776 nt) were identical.  
Complete genome sequences for filoviruses were aligned in CLUSTAL W using 
MEGA v.4.0, and 5’ and 3’ sequence ends were trimmed to obtain a single comparable 
data set.  Similarity scores were calculated by Maximum Composition Likelihood and 
Neighbor Joining methods.  DNA Distance method was applied to the tree showing 
branch length topology.  Consensus trees were derived from 1000 bootstrap iterations.    
For PRRSV, RT-PCR products corresponding to NSP2 from each positive sample 
group (groups A, C and E) were cloned into E. coli using TOPO-TA (Invitrogen). A 
partial NSP2 gene sequence representing the consensus sequence from multiple samples 
was submitted to Genbank under the accession number FJ641193.  The putative 
translation of this consensus sequence was aligned with other Nsp2 PRRSV sequences in 
CLUSTAL W using MEGA v.4.0. 
 
Immunohistochemical assays of REBOV and PRRSV.  Immunohistochemical (IHC) 
assays for detection of EBOV and PRRS viral antigens were performed on formalin-fixed 
paraffin-embedded tissue specimens using a modification of a colorimetric indirect 
immunoalkaline phosphatase method (UltraVision LPValue Large Volume Detection 
System AP Polymer, Thermo Scientific) (S3) . IHC assays included a polyclonal rabbit 
anti-EBOV antibody, a hyperimmuned mouse anti-EBOV antibody (both from Special 
Pathogens Branch, CDC), and a monoclonal mouse anti-PRRS virus antibody (Rural 
Technologies, Inc, Brookings, SD, USA). Both anti-EBOV antibodies cross-react with all 
5 species of EBOV. Appropriate positive and negative controls were run in parallel. 
 
Serological Analyses.  Analysis of sera was performed for PRRSV, CSFV, and FMDV 
using IDEXX HerdChek PRRS 2XR antibody ELISA kit,  IDEXX HerdChek CSFV 
antibody ELISA kit, and Ceditest FMDV-NS ELISA (Prionics AG), respectively EBOV 
IgG detection was performed as previously described by the CDC. 
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Fig. S1.  A topographical map generated using Google Maps showing locations in the 
Philippines from where samples were obtained is shown (©2009 Google – Map data 
©2009 AND Europa Technologies). Samples were collected in five animal groups 
designated groups A-E.  The red + represent REBOV positive sites (Lat.  14°49'3.78"N; 
Long. 120°53'0.01"E: sample group A) and (Lat.   16° 9'35.23"N; Long. 120° 5'5.03"E: 
sample groups C and E) while blue  mark additional sites sampled.  The site of the 
original isolates of REBOV in monkeys is indicated by a yellow Δ.      
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Supporting Table 
 
   Table S1.  Swine samples and diagnostic PCRs 
Group and 
Location 
Sample 
Type 
 # Tissues 
/Pool PCV-2 PRRSV *REBOV 
  Lung 1 + + + 
Group A  Spleen 1 - - + 
(Bulacan) Lymph node 1 - - + 
  Liver 1 - - - 
Group B  Lung 3 + - - 
(Neuva Ecija) Spleen 3 + - - 
  Liver 3 + - - 
Group C* Lung 2 - + + 
(Pangasinan)  Lymph node 2 - + + 
  Spleen 2 - - + 
Group D 
(Batangas) Tonsil 1 + - - 
Group E*  Lung 2 - + - 
(Pangasinan)  Spleen 3 - + + 
  Tonsil 1 - + - 
 
Swine samples and diagnostic PCRs.  Pooled tissue homogenates of similar tissue from 
each of five groups were tested by PCR and found to be positive for Porcine Circovirus-
type 2 (PCV-2) and Porcine Reproductive and Respiratory Syndrome Virus (PRRSV).  
Additionally, conventional RT-PCR directed against the L gene of the Reston ebolavirus 
and/or Taqman realtime RT-PCR were used to test most tissue samples individually for 
the presence of REBOV.  * For clarity, REBOV PCR results are presented as + or – 
based any given results for 1 or more tissues selected for the pool of tissues.  Tissue pool 
describes the number of tissues of each type included from individual animals from their 
respective group. Symbols represented in the table for PCV-2, PRRS, and REBOV PCR 
are: + Positive or - Negative.  *Groups C and E were separate groups of animals at the 
same premise.   
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